Skip to main content
Probi logo

Probi — Investor Relations & Filings

Ticker · PROB ISIN · SE0001280355 LEI · 5493004CJOCT273MU397 ST Manufacturing
Filings indexed 410 across all filing types
Latest filing 2018-03-14 Board/Management Inform…
Country SE Sweden
Listing ST PROB

Probi is a global biotics company specializing in the research, development, and manufacturing of clinically documented probiotic strains. The company provides biotic solutions for dietary supplements and functional foods, targeting specific health needs across various life stages. Its portfolio addresses key areas such as digestive, immune, mental, and metabolic health, alongside specialized formulations for women, children, and healthy aging. Probi's offerings are founded on extensive scientific research and clinical studies to ensure proven efficacy in supporting human health.

Recent filings

Filing Released Lang Actions
Probi names Ole Søgaard Andersen as Interim CEO
Board/Management Information Classification · 1% confidence The document is a short press release announcing a specific change in senior personnel: the appointment of Ole Søgaard Andersen as Interim Chief Executive Officer, replacing the previous CEO. This directly aligns with the definition for Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document length is short (2410 chars), but its content is the primary announcement itself, not an announcement *about* a report, thus ruling out RPA/RNS based on the 'MENU VS MEAL' rule interpretation for primary content.
2018-03-14 English
Probi utser Ole Søgaard Andersen till tillförordnad VD
Board/Management Information Classification · 1% confidence The document is a press release announcing a change in senior management: the appointment of Ole Søgaard Andersen as the interim CEO, replacing the current CEO. This directly corresponds to the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management. The document is short and focuses solely on this personnel change.
2018-03-14 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report Classification · 1% confidence The document is a 'Bokslutskommuniké' (Year-end report) for the period January–December 2017. It contains comprehensive financial statements, segment reporting, management commentary on business trends, and key performance indicators. It is a full financial report for a period shorter than a full fiscal year (or a preliminary full-year report), which fits the definition of an Interim/Quarterly Report (IR) in the provided schema, as it provides substantive financial data and analysis rather than just an announcement of a report. FY 2017
2018-01-25 Swedish
Audit Report / Information 2017
Audit Report / Information Classification · 1% confidence The document is explicitly titled '# Year-end Report' and covers the period 'January – December 2017'. It contains detailed comparative financial tables for 'Full-year 2017' vs 'Full-year 2016', including Net sales, EBITDA, Operating profit, and Earnings per share. It also includes CEO comments, segment analysis, and regional breakdowns, which are characteristic features of a comprehensive annual financial report. Although it is not explicitly labeled '10-K' (which is the SEC filing name for an Annual Report), based on the content (full-year financial performance, comprehensive review), it fits the definition of an Annual Report (AR) or 10-K. Given the context of a non-US company (Swedish company Probi AB, using MSEK/SEK) reporting its year-end results, 'AR' (Audit Report / Information) is the most appropriate classification among the provided options for a comprehensive annual financial statement package, although '10-K' is often used synonymously for the final annual report document type. Since the content is the full annual financial performance review, it is classified as AR, which covers comprehensive reports shorter than a year (IR) or full year (10-K). Given the comprehensive nature covering the full fiscal year, 10-K is the best fit for a full annual report, even if it's not the SEC form itself, as AR is often reserved for standalone audit opinions. However, looking at the definitions, 10-K is 'Official yearly report covering company activity and full financial performance.' This document perfectly matches that description. I will select 10-K. FY 2017
2018-01-25 English
Probi har tecknat betydande avtal för lansering av Functional Food-produkt i Nordamerika
Regulatory Filings Classification · 1% confidence The document is a short press release (1952 characters) announcing a significant agreement for the launch of a Functional Food product in North America. It contains key highlights, financial context (2016 revenue figures), and contact information. It is not a full financial report (like 10-K or IR), nor is it a transcript or a formal regulatory filing like a Director's Dealing or Major Shareholding notification. It is an announcement of a business development that will impact future revenue. Since it is a general business/material event announcement that doesn't fit the specific categories like M&A (TAR) or Capital Change (CAP), and it is not explicitly announcing the publication of a report (RPA), the most appropriate general category for significant, non-standard business updates that impact the company's outlook is the general Regulatory Filings category (RNS), as it is a mandatory disclosure under market abuse regulations ('EU:s marknadsmissbruksförordning'). However, given the content is a major commercial agreement, it is often classified under general news releases. Since there is no specific 'Business Development Announcement' category, RNS serves as the best fit for mandatory, non-standard disclosures.
2017-12-12 Swedish
Probi signed major agreement for launch of Functional Food product in North America
Regulatory Filings Classification · 1% confidence The document is structured as a 'PRESS RELEASE' announcing a significant business event: a major agreement signed for product launch in North America. It details the nature of the agreement, expected impact on revenues, and includes contact information and boilerplate 'ABOUT PROBI' text. This type of announcement, which is not a formal financial report (like 10-K or IR), a specific regulatory filing (like DIRS or DIV), or a transcript, best fits the category for general regulatory announcements or miscellaneous corporate news that doesn't fit elsewhere. Given the options, 'Regulatory Filings' (RNS) serves as the appropriate fallback for significant, non-standard corporate news releases that are mandated for public disclosure (as indicated by the reference to the EU Market Abuse Regulation). It is not an Earnings Release (ER) as it doesn't contain period-specific financial results, nor is it a specific transaction report like M&A (TAR).
2017-12-12 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.